Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Ordinary Shares, nominal value EUR0.05 per share
-
Shares outstanding
-
95,490,450
-
Total 13F shares
-
15,187,964
-
Share change
-
-1,360,429
-
Total reported value
-
$123,726,723
-
Put/Call ratio
-
73%
-
Price per share
-
$8.12
-
Number of holders
-
55
-
Value change
-
-$17,963,859
-
Number of buys
-
29
-
Number of sells
-
35
Institutional Holders of Cellectis S.A. - Ordinary Shares, nominal value EUR0.05 per share (CLLS) as of Q4 2021
As of 31 Dec 2021,
Cellectis S.A. - Ordinary Shares, nominal value EUR0.05 per share (CLLS) was held by
55 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
15,187,964 shares.
The largest 10 holders included
ARK Investment Management LLC, Capital International Investors, PRINCIPAL FINANCIAL GROUP INC, CREDIT SUISSE AG/, Long Focus Capital Management, LLC, BAILLIE GIFFORD & CO, Capital World Investors, Nikko Asset Management Americas, Inc., Sumitomo Mitsui Trust Holdings, Inc., and Bpifrance SA.
This page lists
55
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.